Remus Pharmaceuticals Ltd (REMP)

Currency in INR
940.30
+15.25(+1.65%)
Real-time Data·
Advertisement
REMP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
940.30940.30
52 wk Range
580.001,007.00
Key Statistics
Bid/Ask
910.85 / 943.00
Prev. Close
925.05
Open
940.3
Day's Range
940.3-940.3
52 wk Range
580-1,007
Volume
300
Average Volume (3m)
9.41K
1-Year Change
30.6971%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
REMP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Providers & Services industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Earnings

Latest Release
20/05/2026
EPS / Forecast
20.86 / --
Revenue / Forecast
4.57B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 31.39%
Dividend Yield
0.11%
Industry Median 0.66%
Annualised payout
1.00
Paid annually
5-Years Growth
-
Growth Streak

Compare REMP to Peers and Sector

Metrics to compare
REMP
Peers
Sector
Relationship
P/E Ratio
28.9x52.8x−0.4x
PEG Ratio
−0.810.870.00
Price/Book
3.0x5.6x2.6x
Price / LTM Sales
1.3x4.4x3.1x
Upside (Analyst Target)
-13.4%54.8%
Fair Value Upside
Unlock−2.9%7.6%Unlock

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceutical products and allied products in India and internationally. It is involved in trading of active pharmaceutical ingredients, as well as provides technical and consultancy services to various distributors and contract manufacturing services. The company also offers tablet, hard and soft gel capsules, liquid, dry powder, lyophilized injections, as well as pre-filled syringe, infusions, inhalers, nebulizers, nasal sprays, topical sprays, respules, syrups and oral suspensions, creams, gels, ointments, topical solutions, transdermal patches, sachets, ovules, suppositories, and ophthalmic and other specialised forms. It also exports its products. Remus Pharmaceuticals Limited was incorporated in 2015 and is based in Ahmedabad, India.

Employees
69
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
107.80K0.91%99.12M
Public Companies & Retail Investors
11.68M99.09%10.74B
Total
11.78M100.00%10.84B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Renosen Pharmaceuticals Private Limited0.91%107,80099,122

People Also Watch

2,069.80
CORD
-0.41%
1,230.40
SUDP
+2.95%
122.25
VALO
+0.05%
185.00
OCCL
+3.58%
1,400.10
SENO
-0.26%

FAQ

What Is the Remus Pharmaceuticals (NSE: REMP) Share Price Today?

The Remus Pharmaceuticals stock price today is 940.30 INR.

What Stock Exchange Does Remus Pharmaceuticals (REMP) Trade On?

Remus Pharmaceuticals is listed and trades on the India National Stock Exchange.

What Is the Ticker (Stock Symbol) for Remus Pharmaceuticals?

The stock symbol (also called a 'ticker') for Remus Pharmaceuticals is "REMP."

Does Remus Pharmaceuticals Pay Dividends? What’s The Current REMP Dividend Yield?

Yes, REMP Pays Dividends to its Shareholders. The current Remus Pharmaceuticals dividend yield is 0.11%.

What Is the Current Remus Pharmaceuticals Market Capitalisation?

As of today, Remus Pharmaceuticals (NSE: REMP) market cap is 10.90B INR.

What Is Remus Pharmaceuticals's (REMP) Earnings Per Share (TTM)?

The Remus Pharmaceuticals EPS is currently 31.39 (Trailing Twelve Months).

Is REMP a Buy or Sell From a Technical Analyst Perspective?

Based on today's Remus Pharmaceuticals moving averages and other technical indicators, the daily buy/sell signal for REMP stock is Strong Buy.

How Many Times Has Remus Pharmaceuticals Stock Split?

Remus Pharmaceuticals has split 2 times. (See the REMP stock split history page for full effective split date and price information.)

How Many Employees Does Remus Pharmaceuticals Have?

Remus Pharmaceuticals has 69 employees, based on their latest Companies House report.

What is the current trading status of Remus Pharmaceuticals (NSE: REMP)?

As of 30/09/2026, Remus Pharmaceuticals (REMP) is trading at a share price of 940.30 INR, with a previous close of 925.05 INR. The stock has fluctuated within a day range of 940.30 INR to 940.30 INR, while its 52-week range spans from 580.00 INR to 1,007.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.